Yang Xiaoyun, Huang Qianru, Li An, Chen Yuan, Xu Wei, Li Jianyong, Wang Yaping, Fang Yongjun
Department of Hematology and Oncology, Children's Hospital of Nanjing Medical University.
Key Laboratory of Hematology, Nanjing Medical University.
Medicine (Baltimore). 2020 Jan;99(5):e18438. doi: 10.1097/MD.0000000000018438.
Burkitt lymphoma (BL), an aggressive malignancy, brings a prognosis varying among children, adolescents, and adults. Most of previous retrospective studies of BL focused on a part of population. This study aimed to find the leading prognostic factors in BL among patients of different age groups. World Health Organization classification of lymphoid neoplasms in 2008 and revision in 2016 were used as diagnostic criteria for BL. We compared the laboratory results and clinical manifestations in 2 age groups by Kaplan-Meier survival analysis. Our study strongly indicated that age >14 years and lactate dehydrogenase >570 U/L were 2 powerful prognostic factors for BL. The results indicated that poor prognosis may be for the poor tolerance and low dose of drugs in adolescents and adults.
伯基特淋巴瘤(BL)是一种侵袭性恶性肿瘤,其预后在儿童、青少年和成人中有所不同。以往大多数关于BL的回顾性研究都集中在部分人群。本研究旨在找出不同年龄组BL患者的主要预后因素。采用2008年世界卫生组织淋巴样肿瘤分类及2016年修订版作为BL的诊断标准。通过Kaplan-Meier生存分析比较了2个年龄组的实验室结果和临床表现。我们的研究有力地表明,年龄>14岁和乳酸脱氢酶>570 U/L是BL的两个强有力的预后因素。结果表明,青少年和成人预后较差可能是由于耐受性差和药物剂量低。